Form 8-K - Current report:
SEC Accession No. 0001393905-21-000360
Filing Date
2021-08-05
Accepted
2021-08-05 16:15:57
Documents
6
Period of Report
2021-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT rtsl_8k.htm 8-K 50743
2 FORM OF COMMON STOCK PURCHASE WARRANT rtsl_ex41.htm EX-4.1 94557
3 FORM OF COMMON STOCK PURCHASE WARRANT rtsl_ex42.htm EX-4.2 97285
4 FORM OF SECURITIES PURCHASE AGREEMENT rtsl_ex101.htm EX-10.1 204077
5 FORM OF ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE rtsl_ex102.htm EX-10.2 123182
6 FORM OF LEAK-OUT AGREEMENT rtsl_ex103.htm EX-10.3 19658
  Complete submission text file 0001393905-21-000360.txt   591273
Mailing Address 15800 DOOLEY RD. SUITE 200 ADDISON TX 75001
Business Address 15800 DOOLEY RD. SUITE 200 ADDISON TX 75001 800-497-6059
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

EIN.: 462111820 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55018 | Film No.: 211148392
SIC: 2834 Pharmaceutical Preparations